{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:16:41Z","timestamp":1707524201511},"reference-count":6,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,12]]},"DOI":"10.7759\/cureus.13299","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T09:54:07Z","timestamp":1613123647000},"source":"Crossref","is-referenced-by-count":0,"title":["T-cell Prolymphocytic Leukemia, Cerebriform Variant"],"prefix":"10.7759","author":[{"given":"Jos\u00e9","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Esteves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Teixeira da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Couto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12856","article-title":"Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified","volume":"98","author":"Kawamoto K","year":"2017","unstructured":"Kawamoto K, Miyoshi H, Yanagida E, et al.. Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified. Eur J Haematol. 2017, 98:459-466. 10.1111\/ejh.12856","journal-title":"Eur J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2013.11928902","article-title":"T-cell prolymphocytic leukemia","volume":"26","author":"Graham RL","year":"2013","unstructured":"Graham RL, Cooper B, Krause JR. T-cell prolymphocytic leukemia. Proc (Bayl Univ Med Cent). 2013, 26:19-21. 10.1080\/08998280.2013.11928902","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000402","article-title":"Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia","volume":"134","author":"Staber PB","year":"2019","unstructured":"Staber PB, Herling M, Bellido M, et al.. Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia. Blood. 2019, 134:1132-1143. 10.1182\/blood.2019000402","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0904569","article-title":"The tumor lysis syndrome [published correction appears in N Engl J Med. 2018, 379:1094]","volume":"364","author":"Howard SC","year":"2011","unstructured":"Howard SC, Jones DP, Pui CH. The tumor lysis syndrome [published correction appears in N Engl J Med. 2018, 379:1094]. N Engl J Med. 2011, 364:1844-1854. 10.1056\/NEJMra0904569","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx163","article-title":"Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL)","volume":"28","author":"Jain P","year":"2017","unstructured":"Jain P, Aoki E, Keating M, et al.. Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL). Ann Oncol. 2017, 28:1554-1559. 10.1093\/annonc\/mdx163","journal-title":"Ann Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-020-00566-5","article-title":"Advances and perspectives in the treatment of T-PLL","volume":"15","author":"Braun T","year":"2020","unstructured":"Braun T, von Jan J, Wahnschaffe L, Herling M. Advances and perspectives in the treatment of T-PLL. Curr Hematol Malig Rep. 2020, 15:113-124. 10.1007\/s11899-020-00566-5","journal-title":"Curr Hematol Malig Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/50545-t-cell-prolymphocytic-leukemia-cerebriform-variant","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:24:12Z","timestamp":1707506652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/50545-t-cell-prolymphocytic-leukemia-cerebriform-variant"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":6,"URL":"https:\/\/doi.org\/10.7759\/cureus.13299","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,12]]}}}